000 | 01632 a2200457 4500 | ||
---|---|---|---|
005 | 20250513132549.0 | ||
264 | 0 | _c19980102 | |
008 | 199801s 0 0 eng d | ||
022 | _a0008-543X | ||
024 | 7 |
_a10.1002/(sici)1097-0142(19971215)80:12+<2583::aid-cncr34>3.3.co;2-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDeNardo, S J | |
245 | 0 | 0 |
_aImportance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma. _h[electronic resource] |
260 |
_bCancer _cDec 1997 |
||
300 |
_a2583-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
650 | 0 | 4 |
_aBone Marrow _xdrug effects |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xtherapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
650 | 0 | 4 | _aRadioimmunotherapy |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 | _aWeight Loss |
650 | 0 | 4 |
_aYttrium Radioisotopes _xtherapeutic use |
700 | 1 | _aKroger, L A | |
700 | 1 | _aLamborn, K R | |
700 | 1 | _aMiers, L A | |
700 | 1 | _aO'Donnell, R T | |
700 | 1 | _aKukis, D L | |
700 | 1 | _aRichman, C M | |
700 | 1 | _aDeNardo, G L | |
773 | 0 |
_tCancer _gvol. 80 _gno. 12 Suppl _gp. 2583-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0142(19971215)80:12+<2583::aid-cncr34>3.3.co;2-8 _zAvailable from publisher's website |
999 |
_c9376311 _d9376311 |